Sermorelin sits in an unusual position among research peptides. The molecule was an FDA-approved pharmaceutical (later withdrawn for commercial reasons), it has a legitimate 503A compounded route through licensed pharmacies, and it is also sold as a research chemical by the same vendors that carry BPC-157 and tirzepatide. Two real buyer personas exist for it — and the right pick depends entirely on whether the reader values cost or clinical oversight.
Research-context information only. Sermorelin is the active ingredient in FDA-approved products previously marketed for pediatric growth hormone deficiency; the branded product was withdrawn for commercial reasons, and current research-peptide and 503A-compounded forms are not FDA-approved finished pharmaceuticals. Protocols, doses, and reactions reported below come from clinical trials and community sources. This article reports what has been documented, not what should be done. Consult a licensed physician for personal medical decisions.
This guide covers both routes honestly. For the molecule itself, see the sermorelin peptide page. For protocols, see the sermorelin dosing guide.
Quick Price Comparison: Research Vendor vs Telehealth
Glacier Aminos
10 mg vial
$60.99
$6.10/mg
~$18-22/month
EZ Peptides
5 mg vial
$35.00
$7.00/mg
~$21-25/month
Ion Peptide
$39.00
$7.80/mg
~$23-28/month
Ascension Peptides
$85.00
$8.50/mg
~$25-30/month
Telehealth (compounded)
Monthly fill
$200-400/mo
n/a
$200-400/month
Research-vendor prices listed are pre-discount; vendor coupons regularly reduce another 15-50% through site-wide promo codes. Telehealth pricing typically includes physician consult, compounded fill, and cold-chain shipping. For context across the sermorelin vendor cohort, our Peptide Price Index Q1 2026 tracked 122 observations across 10 vendors — the widest vendor pool of any deep-dive peptide — with a median of $8.00/mg and most listings clustered tightly in the $7-$10/mg band.
What Sermorelin Is (Briefly)
Sermorelin is a synthetic version of the first 29 amino acids of human growth hormone-releasing hormone (GHRH 1-29), the shortest fragment with full GHRH bioactivity (Prakash & Goa, 1999). It binds the GHRH receptor on pituitary somatotrophs and triggers natural GH release in pulsatile patterns, rather than replacing the hormone itself.
The molecule was previously FDA-approved as a diagnostic for pediatric growth hormone deficiency, which left a clinical safety record most research peptides lack. It was withdrawn from the US finished-drug market for commercial reasons, not safety findings.
For the full mechanism, evidence base, and benefit ranking, see sermorelin benefits and the sermorelin results timeline.
The Two Routes — When Each Makes Sense
Route A: Research peptide
Profile of users this route typically fits: people who self-manage protocols, are comfortable with reconstitution math, have done at least one prior peptide cycle, and accept that the product is sold "for research use only" with no medical oversight bundled in.
What community discussion commonly references:
Per-mg pricing roughly 8-15x lower than telehealth
COA-backed product from established vendors (Janoshik / MZ Biolabs verification typical)
Self-directed bloodwork (IGF-1, fasting glucose) ordered separately through services like HealthLabs or Marek
Reconstitution and dosing handled by the user — see the sermorelin dosing guide
Cycling typically follows community-documented 8-on / 8-off frameworks
Trade-off to acknowledge: No medical oversight. No prescription. No structured response monitoring unless the user arranges it themselves.
Route B: Telehealth / 503A-compounded
Profile of users this route typically fits: people who want a prescriber, structured intake bloodwork, an official compounded fill from a licensed pharmacy, and are willing to pay 8-15x more for the clinical wrapper.
What documented telehealth intake flows typically look like:
Online intake form covering medical history, goals, and medications
Baseline labs ordered by the prescriber — IGF-1, CMP, often thyroid and fasting glucose
Prescriber consult (video or async) reviewing labs and writing the script
503A compounding pharmacy fills the script and ships cold-chain
Follow-up bloodwork at 8-12 weeks to check IGF-1 response and adjust dose
Trade-off to acknowledge: The compounded product is not an FDA-approved finished pharmaceutical. 503A compounding is legal in the US for individual prescriptions but does not carry the same regulatory testing as an approved drug. Cost is meaningfully higher than research-grade.
Both routes are legitimate. Neither is universally "better" — the right pick depends on the reader's comfort with self-management vs cost-of-oversight.
Research Vendor Breakdown
Research-grade sermorelin arrives as a lyophilized (freeze-dried) powder cake in a sealed glass vial. Two vial sizes dominate the catalog: 5 mg and 10 mg. At a community-typical 100-300 mcg/day dose, a 5 mg vial covers roughly 17-50 days; a 10 mg vial covers 33-100 days — both within the documented 14-28 day reconstituted-stability window if reconstituted in halves or used quickly.
Standard COA expectations referenced in community vendor threads:
HPLC purity ≥ 98%
Mass spec confirming ~3,358 Da (GHRH 1-29 fragment with N-terminal acetyl modification)
Identity peak consistent with the 29-amino-acid sequence
Endotoxin and residual solvent screening
Vendors most commonly cited for verifiable third-party COAs include those who publish Janoshik Analytical task numbers (lookupable at janoshik.com), MZ Biolabs reports, or Colmaric Analyticals. In-house-only testing is widely treated as a red flag.
For the full $/mg comparison and live ranked vendor list with current pricing and stock, see Best Sermorelin Vendors.
Telehealth Route Deep Dive
Why sermorelin can be legitimately compounded
503A compounding pharmacies are licensed under the FDA Drug Quality and Security Act to compound drugs for individual patients pursuant to a valid prescription. Sermorelin acetate is on bulk drug substance lists used by 503A pharmacies, which is why a clinician can write a script and have it filled. This is a separate regulatory pathway from the FDA-approved finished-drug pathway.
Compounded sermorelin is not an FDA-approved finished pharmaceutical, and the bulk substance regulatory landscape continues to evolve — readers comparing routes should verify current status with their prescriber.
Typical telehealth intake
What documented telehealth intake flows describe:
Intake form — medical history, current medications, goals (energy, body composition, sleep, recovery)
Baseline bloodwork — IGF-1 (the primary downstream marker), CMP, often TSH/free T4 and fasting glucose
Prescriber consult — video or async review of labs and goals; some clinics gate sermorelin behind documented IGF-1 in the lower quartile for age
Compound + ship — 503A pharmacy fills the script; sermorelin ships in dry vials with bacteriostatic water and syringes, cold-chain
Follow-up labs at 8-12 weeks — IGF-1 re-check to confirm response; dose adjustment as documented
For the bloodwork side specifically — what to monitor at baseline and on cycle — see the broader biomarker reference work on the site for IGF-1 reference ranges.
Cost comparison: research vs telehealth at 100 mcg/day
Research-grade (5 mg vial, mid-range vendor)
~$22-25
~$260-300
Vial, BAC water (separate), COA
Research-grade (10 mg vial, kit pricing)
~$15-18
~$180-220
$200-400
$2,400-4,800
Script, compounded fill, intake labs, follow-up consult
The gap is roughly 8-15x. The premium covers physician oversight, compounded sterile fill, intake/follow-up bloodwork, and prescription infrastructure — not the molecule.
Telehealth providers covering sermorelin
For readers choosing the prescribed route, the providers below currently cover sermorelin via 503A compounding with licensed clinician oversight and shipping in all 50 states.